Session R: Management of HCV in People who Inject Drugs
| Friday, September 21, 2018 |
| 10:00 AM - 12:00 PM |
| Sala I + II |
Speaker
MD Brian Conway
Medical Director and President
Vancouver Infectious Diseases Centre
Dr Massimo Colombo
Head Liver Research Center
Humanitas Hospital Rozzano
Dr Alessio Aghemo
Professor of Gastroenterology
Humanitas University
Professor Carla Treloar
Scientia Professor, Centre for Social Research in Health and the Social Policy Research Centre
UNSW Sydney
Questions & Discussion
Questions & Discussion
11:20 AM - 11:30 AMBiography
Dr. Evan Cunningham
Research Fellow, Viral Hepatitis and Clinical Research Program
Kirby Institute
Adherence To Sofosbuvir And Velpatasvir Among People With Chronic Hcv Infection And Recent Injection Drug Use: The SIMPLIFY Study
11:30 AM - 11:45 AMBiography
Evan is a postdoctoral fellow with the viral hepatitis clinical research program as part of the Kirby Institute. His research focuses on the clinical epidemiology of HCV infection in vulnerable populations.
Dr Behzad Hajarizadeh
Associate Professor
Unsw / Kirby Institute
Direct-Acting Antiviral Therapy For Hepatitis C Virus Infection Among People Who Inject Drugs: A Systematic Review And Meta-Analysis
11:45 AM - 12:00 PMBiography
Behzad Hajarizadeh is an epidemiologist, a Lecturer in UNSW Sydney and a fellow of Australian National Health and Medical Research Council. He trained as a Medical Practitioner and has an MPH and a PhD in Medicine. Research interests include HCV care in prison setting and among people who inject drugs.
Chair
Rui Marinho
MD, PhD
Hospital Santa Maria
Lynn Taylor
Research Professor
University of Rhode Island
